Filing Flows › Maravai Lifesciences Holdings (MRVI) › Capital expenditures
Maravai Lifesciences Holdings (MRVI) capital expenditures by quarter
Maravai Lifesciences Holdings' capital expenditures were $523K in Q3 2026 (third quarter 2026), +41% from Q2 2026. Over the last 3 quarters it ranged from $370K (Q2 2026) to $4.4M (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $523K | +41% | — |
| Q2 2026 | $370K | -92% | — |
| Q1 2026 | $4.4M | — | — |
Q3 2026 at a glance
Maravai Lifesciences Holdings, Q3 2026: revenue $45.9M (+10% year over year), operating margin -45.0%, net loss $24.0M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Maravai Lifesciences Holdings' capital expenditures?
Maravai Lifesciences Holdings' capital expenditures were $523K in Q3 2026 (third quarter 2026), +41% from Q2 2026.
How has Maravai Lifesciences Holdings' capital expenditures changed?
Over the last 3 quarters it ranged from $370K (Q2 2026) to $4.4M (Q1 2026).
Q3 2026 results → · How Maravai Lifesciences Holdings makes money →